European Patent Attorney
Eivind has extensive experience from patenting within life-sciences. He has had IP-responsibility in many innovation projects concerning antibiotics, pharmaceutical formulations, cell therapy, gene therapy and antibodies. He is passionate for connecting patent protection to business-plans, so customers get value for money. Furthermore, he has worked a lot with Freedom-to-operate (FTO) analysis for minimizing the risk of launching a new product or service. In short, his core competence involves:
• Securing valuable IP in innovation projects; outlinging suitable patenting strategies.
• Patentability assessment and FTO-analysis
• Drafting of patent applications; directing their prosecution
Both patentability, enforceability, cost, timing of launch, important markets, important production sites, and competitor activities are aspects that should be included in the IP strategy of innovative companies operating globally.
Eivind has over two decades of patenting experience, but he just recently took the EQE-exam and qualified as a European Patent Attorney. He has been working for Onsagers since August 2022.
2022 – d.d: Onsagers AS, European Patent Attorney
2017 – 2022: Inven2, IPR Manager
2015 – 2017: Yara International, Patent Manager
2007 – 2015: Xellia Pharmaceuticals (formerly Alpharma), Patent Specialist
2001 – 2007: Norwegian Patent Office, Examiner
2000, Master of Science, Biochemistry, University of Oslo